Childhood Grade II Meningioma

12 clinical trials · Condition

Record	Firm	Date
Efficacy of 68Ga-DOTATOC Positron Emission Tomography (PET) CT in Children and Young Adults With Brain Tumors (NCT02194452)	Sue O'Dorisio	2013-09-01
Gamma-Secretase Inhibitor RO4929097 in Treating Young Patients With Relapsed or Refractory Solid Tumors, CNS Tumors, Lymphoma, or T-Cell Leukemia (NCT01088763)	National Cancer Institute (NCI)	2010-03-01
Vorinostat and Temozolomide in Treating Young Patients With Relapsed or Refractory Primary Brain Tumors or Spinal Cord Tumors (NCT01076530)	National Cancer Institute (NCI)	2010-02-01
ABT-888 and Temozolomide in Treating Young Patients With Recurrent or Refractory CNS Tumors (NCT00946335)	National Cancer Institute (NCI)	2009-07-01
Ispinesib in Treating Young Patients With Relapsed or Refractory Solid Tumors or Lymphoma (NCT00363272)	National Cancer Institute (NCI)	2006-06-01
AZD2171 in Treating Young Patients With Recurrent, Progressive, or Refractory Primary CNS Tumors (NCT00326664)	National Cancer Institute (NCI)	2006-03-01
Lenalidomide in Treating Young Patients With Recurrent, Progressive, or Refractory CNS Tumors (NCT00100880)	National Cancer Institute (NCI)	2004-11-01
Collecting and Storing Blood and Brain Tumor Tissue Samples From Children With Brain Tumors (NCT00919750)	Children's Oncology Group	2004-02-16
Cilengitide in Treating Children With Refractory Primary Brain Tumors (NCT00063973)	National Cancer Institute (NCI)	2003-07-01
Temozolomide and O6-Benzylguanine in Treating Children With Recurrent Brain Tumors (NCT00052780)	National Cancer Institute (NCI)	2002-10-01
FR901228 in Treating Children With Refractory or Recurrent Solid Tumors or Leukemia (NCT00053963)	National Cancer Institute (NCI)	2002-09-01
Irinotecan in Treating Children With Refractory Solid Tumors (NCT00004078)	Children's Oncology Group	1999-10-01

Track Childhood Grade II Meningioma automatically

Every clearance here is in the API, with alerts when new ones post.